Loading clinical trials...
Loading clinical trials...
A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients
Conditions
Interventions
Pritor (Telmisartan , BAY68-9291)
Locations
4
Croatia
Many Locations, Croatia
Many Locations, Poland
Many Locations, Slovakia
Many Locations, Slovenia
Start Date
September 1, 2006
Primary Completion Date
November 1, 2009
Completion Date
November 1, 2009
Last Updated
January 20, 2010
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions